Building Scale Through Affordable Healthcare $ZOTA

$ZOTA continues to strengthen its position in India's affordable healthcare space through the rapid expansion of its Davaindia pharmacy network. The company delivered robust revenue growth in its latest quarter, supported by strong store additions and healthy same-store sales. While profitability remains under pressure due to expansion-related investments, management remains focused on scaling the business with plans to add 500–700 new stores in FY27, taking the long-term network target beyond 5,000 stores. As a retail pharmacy business, Zota does not have a conventional order book; instead, its revenue visibility is driven by recurring demand across its expanding store network. Management remains optimistic about improving profitability through operating leverage as newly opened stores mature and by increasing the contribution of higher-margin private-label products. The strategy reflects a balance between aggressive expansion and sustainable earnings growth. With a market capitalisation of around ₹5,000 crore, investors should monitor store additions, same-store sales growth, margin expansion, and the path toward profitability, as these will be the key drivers of value creation over the coming years.